Past Glory and Future Promise: Maximizing and Improving Understanding of Atrophy Patterns in the Diagnosis of Degenerative Dementias

References

1. ↵
   Whitehouse PJ, Price DL, Struble RG, Clark AW, Coyle JT, Delon MR. Alzheimer’s disease and senile dementia: loss of neurons in the basal forebrain. Science 1982;215:1237–1239

   Abstract/FREE Full Text
2. ↵
   De Leon MJ, Ferris SH, George AE, Reisberg B, Kricheff II, Gershon S. Computed tomography evaluations of brain-behavior relationships in senile dementia of the Alzheimer’s type. Neurobiol Aging 1980;1:69–79

   CrossRefPubMedWeb of Science
3. ↵
   Schenk D, Barbour R, Dunn W, et al. Immunization with amyloid-beta attenuates Alzheimer-disease-like pathology in the PDAPP mouse. Nature 1999;400:173–177

   CrossRefPubMedWeb of Science
4. ↵
   Korth C, May BC, Cohen FE, Prusiner SB. Acridine and phenothiazine derivatives as pharmacotherapeutics for prion disease. Proc Natl Acad Sci USA 2001;98:9836–9841

   Abstract/FREE Full Text
5. ↵
   Braak H, Braak E. Evolution of neuronal changes in the course of Alzheimer’s disease. J Neural Transm 1998;53[Suppl]:S127–S140

   CrossRef
6. ↵
   Jack CR Jr, Petersen RC, Xu Y, et al. Rates of hippocampal atrophy correlate with change in clinical status in aging and AD. Neurology 2000;55:484–489

   Abstract/FREE Full Text
7. ↵
   Du AT, Schuff N, Amend D, et al. Magnetic resonance imaging of the entorhinal cortex and hippocampus in mild cognitive impairment and Alzheimer’s disease. J Neurol Neurosurg Psychiatry 2001;71:441–447

   Abstract/FREE Full Text
8. ↵
   Miller BL, Moats R, Shonk T, Ernst T, Wooley S, Ross BD. Abnormalities of cerebral myo-inositol in patients with early Alzheimer disease. Radiology 1993;187:334–339
9. ↵
   Small GW, Mazziotta JC, Collins MT, et al. Apolipoprotein E type 4 allele and cerebral glucose metabolism in relatives at risk for familial Alzheimer disease. JAMA 1995;273:942–947

   CrossRefPubMedWeb of Science
10. ↵
    Reiman EM, Caselli RJ, Yun LS. Preclinical evidence of alzheimer’s disease in persons homozygous for the epsilon 4 allele for apolipoprotein E. N Eng J Med 1996;334:752–758

    CrossRefPubMedWeb of Science
11. ↵
    Bookheimer SY, Strojwas MH, Cohen MS, et al. Patterns of brain activation in people at risk for Alzheimer’s disease. N Engl J Med 2000;343:450–456

    CrossRefPubMedWeb of Science
12. ↵
    Neary D, Snowden JS, Shields RA. Single photon emission tomography using ^99mTc-HM-PAO in the investigation of dementia. J Neurol Neurosurg Psychiatry 1987;50:1101–1109

    Abstract/FREE Full Text
13. ↵
    Galton CJ, Patterson K, Graham K, et al. Differing patterns of temporal atrophy in Alzheimer’s disease and semantic dementia. Neurology 2001;57:216–225

    Abstract/FREE Full Text
14. ↵
    Miller BL, Boone K, Geschwind D, Wilhelmsen K. Pick’s Disease and Frontotemporal dementias: emerging clinical and molecular concepts. The Neurologist 1999;57:5205–5212
15. ↵
    Vinters HV, Ellis WG, Zarow C, et al. Neuropathologic substrates of ischemic vascular dementia. J Neuropathol Exp Neurol 2000;59:931–9

    PubMedWeb of Science
16. ↵
    Galasko D, Hansen LA, Katzman R, et al. Clinical-neuropathological correlations in Alzheimer’s disease and related dementias. Arch Neurol 1994;51:888–895

    CrossRefPubMedWeb of Science
17. ↵
    Bacskai BJ, Kajdasz ST, Christie RH, et al. Imaging of amyloid-beta deposits in brains of living mice permits direct observation of clearance of plaques with immunotherapy. Nat Med 2001;7:369–372

    CrossRefPubMedWeb of Science
18. ↵
    Demaerel P, Heiner L, Robberecht W, et al. Diffusion-weighted MRI in sporadic Creutzfeldt-Jakob disease. Neurology 1999;52:205–208

    Abstract/FREE Full Text
19. ↵
    Will RG, Zeidler M, Stewart GE, et al. Diagnosis of new variant Creutzfeldt-Jakob disease. Ann Neurol 2000;47:575–58

    CrossRefPubMedWeb of Science